The withdrawal of antiepileptic drugs in patients with low-grade and anaplastic glioma

References

• van Breemen MS, Wilms EB, Vecht CJ. Epilepsy in patients with brain tumours: epidemiology, mechanisms, and management. Lancet Neurol. 2007;6(5):421–430.
   PubMed Web of Science ®Google Scholar
• Ruda R, Bello L, Duffau H, et al. Seizures in low-grade gliomas: natural history, pathogenesis, and outcome after treatments. NeuroOncol. 2012;14(Suppl 4):iv55–iv64.
   Google Scholar
• Klein M, Engelberts NH, van der Ploeg HM, et al. Epilepsy in low-grade gliomas: the impact on cognitive function and quality of life. Ann Neurol. 2003;54(4):514–520.
   PubMed Web of Science ®Google Scholar
• Smits A, Duffau H. Seizures and the natural history of World Health Organization grade II gliomas: a review. Neurosurgery. 2011;68(5):1326–1333.
   PubMed Web of Science ®Google Scholar
• You G, Sha ZY, Yan W, et al. Seizure characteristics and outcomes in 508 Chinese adult patients undergoing primary resection of low-grade gliomas: a clinicopathological study. NeuroOncol. 2012;14(2):230–241.
   Google Scholar
• Afshari D, Moradian N. Evaluating the rate of recurrence of epilepsy after therapy discontinuation in 2-year seizure-free epileptic patients. Int J Neurosci. 2012;122(10):598–601.
   PubMed Web of Science ®Google Scholar
• Chang EF, Potts MB, Keles GE, et al. Seizure characteristics and control following resection in 332 patients with low-grade gliomas. J Neurosurg. 2008;108(2):227–235.
   PubMed Web of Science ®Google Scholar
• Koekkoek JA, Kerkhof M, Dirven L, et al. Seizure outcome after radiotherapy and chemotherapy in low-grade glioma patients: a systematic review. Neuro Oncol. 2015;17(7):924–934.
   PubMed Web of Science ®Google Scholar
• van den Bent MJ. Practice changing mature results of RTOG study 9802: another positive PCV trial makes adjuvant chemotherapy part of standard of care in low-grade glioma. Neuro Oncol. 2014;16(12):1570–1574.
   PubMed Web of Science ®Google Scholar
• Lossius MI, Hessen E, Mowinckel P, et al. Consequences of antiepileptic drug withdrawal: a randomized, double-blind study (Akershus Study). Epilepsia. 2008;49(3):455–463.
   PubMed Web of Science ®Google Scholar
• Ramos-Lizana J, Aguirre-Rodriguez J, Aguilera-Lopez P, et al. Recurrence risk after withdrawal of antiepileptic drugs in children with epilepsy: a prospective study. Eur J Paediatr Neurol. 2010;14(2):116–124.
   PubMed Web of Science ®Google Scholar
• Das RR, Artsy E, Hurwitz S, et al. Outcomes after discontinuation of antiepileptic drugs after surgery in patients with low grade brain tumors and meningiomas. J Neurooncol. 2012;107(3):565–570.
   PubMed Web of Science ®Google Scholar
• Riva M. Brain tumoral epilepsy: a review. Neurol Sci. 2005;26(Suppl 1):S40–S42.
   PubMed Web of Science ®Google Scholar
• Pallud J, Le Van Quyen M, Bielle F, et al. Cortical GABAergic excitation contributes to epileptic activities around human glioma. Sci Transl Med. 2014;6(244):244ra89.
   PubMed Web of Science ®Google Scholar
• Thom M, Blumcke I, Aronica E. Long-term epilepsy-associated tumors. Brain Pathol. 2012;22(3):350–379.
   PubMed Web of Science ®Google Scholar
• Kerkhof M, Vecht CJ. Seizure characteristics and prognostic factors of gliomas. Epilepsia. 2013;54(Suppl 9):12–17.
   PubMed Web of Science ®Google Scholar
• Vecht CJ, Kerkhof M, Duran-Pena A. Seizure prognosis in brain tumors: new insights and evidence-based management. Oncologist. 2014;19(7):751–759.
   PubMed Web of Science ®Google Scholar
• Leighton C, Fisher B, Bauman G, et al. Supratentorial low-grade glioma in adults: an analysis of prognostic factors and timing of radiation. J Clin Oncol. 1997;15(4):1294–1301.
   PubMed Web of Science ®Google Scholar
• van Veelen ML, Avezaat CJ, Kros JM, et al. Supratentorial low grade astrocytoma: prognostic factors, dedifferentiation, and the issue of early versus late surgery. J Neurol Neurosurg Psychiatry. 1998;64(5):581–587.
   PubMed Web of Science ®Google Scholar
• Kerkhof M, Dielemans JC, van Breemen MS, et al. Effect of valproic acid on seizure control and on survival in patients with glioblastoma multiforme. Neuro Oncol. 2013;15(7):961–967.
   PubMed Web of Science ®Google Scholar
• van Breemen MS, Rijsman RM, Taphoorn MJ, et al. Efficacy of anti-epileptic drugs in patients with gliomas and seizures. J Neurol. 2009;256(9):1519–1526.
   PubMed Web of Science ®Google Scholar
• Pallud J, Audureau E, Blonski M, et al. Epileptic seizures in diffuse low-grade gliomas in adults. Brain. 2014;137(Pt 2):449–462.
   PubMed Web of Science ®Google Scholar
• Duffau H, Capelle L. Preferential brain locations of low-grade gliomas. Cancer. 2004;100(12):2622–2626.
   PubMed Web of Science ®Google Scholar
• Koekkoek JA, Dirven L, Heimans JJ, et al. Seizure reduction in a low-grade glioma: more than a beneficial side effect of temozolomide. J Neurol Neurosurg Psychiatry. 2014;86(4):366–373.
   PubMed Web of Science ®Google Scholar
• Chaichana KL, Parker SL, Olivi A, et al. Long-term seizure outcomes in adult patients undergoing primary resection of malignant brain astrocytomas. Clinical article. J Neurosurg. 2009;111(2):282–292.
   PubMed Web of Science ®Google Scholar
• Luyken C, Blumcke I, Fimmers R, et al. The spectrum of long-term epilepsy-associated tumors: long-term seizure and tumor outcome and neurosurgical aspects. Epilepsia. 2003;44(6):822–830.
   PubMed Web of Science ®Google Scholar
• Thom M, Toma A, An S, et al. One hundred and one dysembryoplastic neuroepithelial tumors: an adult epilepsy series with immunohistochemical, molecular genetic, and clinical correlations and a review of the literature. J Neuropathol Exp Neurol. 2011;70(10):859–878.
   PubMed Web of Science ®Google Scholar
• Southwell DG, Garcia PA, Berger MS, et al. Long-term seizure control outcomes after resection of gangliogliomas. Neurosurgery. 2012;70(6):1406–1413.
   PubMed Web of Science ®Google Scholar
• Englot DJ, Berger MS, Barbaro NM, et al. Factors associated with seizure freedom in the surgical resection of glioneuronal tumors. Epilepsia. 2012;53(1):51–57.
   PubMed Web of Science ®Google Scholar
• Maurice C, Mason WP. Seizure management in patients with gliomas. Expert Rev Neurother. 2014;14(4):367–377.
   PubMed Web of Science ®Google Scholar
• Ruda R, Magliola U, Bertero L, et al. Seizure control following radiotherapy in patients with diffuse gliomas: a retrospective study. Neuro Oncol. 2013;15(12):1739–1749.
   PubMed Web of Science ®Google Scholar
• van den Bent MJ, Afra D, de WO, et al. Long-term efficacy of early versus delayed radiotherapy for low-grade astrocytoma and oligodendroglioma in adults: the EORTC 22845 randomised trial. Lancet (London, England). 2005;366(9490):985–990.
   PubMed Web of Science ®Google Scholar
• Plathow C, Schulz-Ertner D, Thilman C, et al. Fractionated stereotactic radiotherapy in low-grade astrocytomas: long-term outcome and prognostic factors. Int J Radiat Oncol Biol Phys. 2003;57(4):996–1003.
   PubMed Web of Science ®Google Scholar
• Pace A, Vidiri A, Galie E, et al. Temozolomide chemotherapy for progressive low-grade glioma: clinical benefits and radiological response. Ann Oncol. 2003;14(12):1722–1726.
   PubMed Web of Science ®Google Scholar
• Tosoni A, Franceschi E, Ermani M, et al. Temozolomide three weeks on and one week off as first line therapy for patients with recurrent or progressive low grade gliomas. J Neurooncol. 2008;89(2):179–185.
   PubMed Web of Science ®Google Scholar
• Ngo L, Nei M, Glass J. Temozolomide treatment of refractory epilepsy in a patient with an oligodendroglioma. Epilepsia. 2006;47(7):1237–1238.
   PubMed Web of Science ®Google Scholar
• Koekkoek JA, Dirven L, Heimans JJ, et al. Seizure reduction is a prognostic marker in low-grade glioma patients treated with temozolomide. J Neurooncol. 2016;126(2):347–354.
   PubMed Web of Science ®Google Scholar
• Sherman JH, Moldovan K, Yeoh HK, et al. Impact of temozolomide chemotherapy on seizure frequency in patients with low-grade gliomas. J Neurosurg. 2011;114(6):1617–1621.
   PubMed Web of Science ®Google Scholar
• Frenay MP, Fontaine D, Vandenbos F, et al. First-line nitrosourea-based chemotherapy in symptomatic non-resectable supratentorial pure low-grade astrocytomas. Eur J Neurol. 2005;12(9):685–690.
   PubMed Web of Science ®Google Scholar
• Soffietti R, Ruda R, Bradac GB, et al. PCV chemotherapy for recurrent oligodendrogliomas and oligoastrocytomas. Neurosurgery. 1998;43(5):1066–1073.
   PubMed Web of Science ®Google Scholar
• Glauser T, Ben-Menachem E, Bourgeois B, et al. Updated ILAE evidence review of antiepileptic drug efficacy and effectiveness as initial monotherapy for epileptic seizures and syndromes. Epilepsia. 2013;54(3):551–563.
   PubMed Web of Science ®Google Scholar
• Armstrong TS, Grant R, Gilbert MR, et al. Epilepsy in glioma patients: mechanisms, management, and impact of anticonvulsant therapy. Neuro Oncol. 2015;18(6):779–789.
   Web of Science ®Google Scholar
• Rossetti AO, Jeckelmann S, Novy J, et al. Levetiracetam and pregabalin for antiepileptic monotherapy in patients with primary brain tumors. A phase II randomized study. Neuro Oncol. 2014;16(4):584–588.
   PubMed Web of Science ®Google Scholar
• Bobustuc GC, Baker CH, Limaye A, et al. Levetiracetam enhances p53-mediated MGMT inhibition and sensitizes glioblastoma cells to temozolomide. Neuro Oncol. 2010;12(9):917–927.
   PubMed Web of Science ®Google Scholar
• Happold C, Gorlia T, Chinot O, et al. Does valproic acid or levetiracetam improve survival in glioblastoma? A pooled analysis of prospective clinical trials in newly diagnosed glioblastoma. J Clin Oncol. 2016;34(7):731–739.
   PubMed Web of Science ®Google Scholar
• Redjal N, Reinshagen C, Le A, et al. Valproic acid, compared to other antiepileptic drugs, is associated with improved overall and progression-free survival in glioblastoma but worse outcome in grade II/III gliomas treated with temozolomide. J Neurooncol. 2016;127(3):505–514.
   PubMed Web of Science ®Google Scholar
• Maschio M, Dinapoli L, Zarabla A, et al. Outcome and tolerability of topiramate in brain tumor associated epilepsy. J Neurooncol. 2008;86(1):61–70.
   PubMed Web of Science ®Google Scholar
• Maschio M, Dinapoli L, Sperati F, et al. Oxcarbazepine monotherapy in patients with brain tumor-related epilepsy: open-label pilot study for assessing the efficacy, tolerability and impact on quality of life. J Neurooncol. 2012;106(3):651–656.
   PubMed Web of Science ®Google Scholar
• Maschio M, Dinapoli L, Mingoia M, et al. Lacosamide as add-on in brain tumor-related epilepsy: preliminary report on efficacy and tolerability. J Neurol. 2011;258(11):2100–2104.
   PubMed Web of Science ®Google Scholar
• Glantz MJ, Cole BF, Forsyth PA, et al. Practice parameter: anticonvulsant prophylaxis in patients with newly diagnosed brain tumors. Report of the Quality Standards Subcommittee of the American Academy of Neurology. Neurology. 2000;54(10):1886–1893.
   PubMed Web of Science ®Google Scholar
• Shih JJ, Ochoa JG. A systematic review of antiepileptic drug initiation and withdrawal. Neurologist. 2009;15(3):122–131.
   PubMed Web of Science ®Google Scholar
• Weller M, Gorlia T, Cairncross JG, et al. Prolonged survival with valproic acid use in the EORTC/NCIC temozolomide trial for glioblastoma. Neurology. 2011;77(12):1156–1164.
   PubMed Web of Science ®Google Scholar
• Shields LB, Choucair AK. Management of low-grade gliomas: a review of patient-perceived quality of life and neurocognitive outcome. World Neurosurg. 2014;82(1–2):e299–309.
   PubMed Web of Science ®Google Scholar
• Kanner AM. Suicidality and epilepsy: a complex relationship that remains misunderstood and underestimated. Epilepsy Curr. 2009;9(3):63–66.
   PubMed Web of Science ®Google Scholar
• Mbizvo GK, Dixon P, Hutton JL, et al. The adverse effects profile of levetiracetam in epilepsy: a more detailed look. Int J Neurosci. 2014;124(9):627–634.
   PubMed Web of Science ®Google Scholar
• Meador KJ, Loring DW, Allen ME, et al. Comparative cognitive effects of carbamazepine and phenytoin in healthy adults. Neurology. 1991;41(10):1537–1540.
   PubMed Web of Science ®Google Scholar
• Meador KJ, Loring DW, Ray PG, et al. Differential cognitive and behavioral effects of carbamazepine and lamotrigine. Neurology. 2001;56(9):1177–1182.
   PubMed Web of Science ®Google Scholar
• Aktekin B, Dogan EA, Oguz Y, et al. Withdrawal of antiepileptic drugs in adult patients free of seizures for 4 years: a prospective study. Epilepsy Behav. 2006;8(3):616–619.
   PubMed Web of Science ®Google Scholar
• Specchio LM, Beghi E. Should antiepileptic drugs be withdrawn in seizure-free patients? CNS Drugs. 2004;18(4):201–212.
   PubMed Web of Science ®Google Scholar
• Medical Research Council Antiepileptic Drug Withdrawal Study Group. Randomised study of antiepileptic drug withdrawal in patients in remission. Lancet (London, England). 1991;337(8751):1175–1180.
   PubMed Web of Science ®Google Scholar
• Camfield P, Camfield C. The frequency of intractable seizures after stopping AEDs in seizure-free children with epilepsy. Neurology. 2005;64(6):973–975.
   PubMed Web of Science ®Google Scholar
• Beghi E, Giussani G, Grosso S, et al. Withdrawal of antiepileptic drugs: guidelines of the Italian league against epilepsy. Epilepsia. 2013;54(Suppl 7):2–12.
   PubMed Web of Science ®Google Scholar
• Su L, Di Q, Yu N, et al. Predictors for relapse after antiepileptic drug withdrawal in seizure-free patients with epilepsy. J Clin Neurosci. 2013;20(6):790–794.
   PubMed Web of Science ®Google Scholar
• Hawash KY, Rosman NP. Do partial seizures predict an increased risk of seizure recurrence after antiepilepsy drugs are withdrawn? J Child Neurol. 2003;18(5):331–337.
   PubMed Web of Science ®Google Scholar
• Chadwick D. Starting and stopping treatment for seizures and epilepsy. Epilepsia. 2006;47(Suppl 1):58–61.
   PubMed Web of Science ®Google Scholar
• Kim YD, Heo K, Park SC, et al. Antiepileptic drug withdrawal after successful surgery for intractable temporal lobe epilepsy. Epilepsia. 2005;46(2):251–257.
   PubMed Web of Science ®Google Scholar
• Lee SY, Lee JY, Kim DW, et al. Factors related to successful antiepileptic drug withdrawal after anterior temporal lobectomy for medial temporal lobe epilepsy. Seizure. 2008;17(1):11–18.
   PubMed Web of Science ®Google Scholar
• Berg AT, Vickrey BG, Langfitt JT, et al. Reduction of AEDs in postsurgical patients who attain remission. Epilepsia. 2006;47(1):64–71.
   PubMed Web of Science ®Google Scholar
• Braun KP, Schmidt D. Stopping antiepileptic drugs in seizure-free patients. Curr Opin Neurol. 2014;27(2):219–226.
   PubMed Web of Science ®Google Scholar
• Boshuisen K, Arzimanoglou A, Cross JH, et al. Timing of antiepileptic drug withdrawal and long-term seizure outcome after paediatric epilepsy surgery (TimeToStop): a retrospective observational study. Lancet Neurol. 2012;11(9):784–791.
   PubMed Web of Science ®Google Scholar
• Mansouri A, Alhadid K, Valiante TA. Sudden unexpected death in epilepsy following resective epilepsy surgery in two patients withdrawn from anticonvulsants. J Clin Neurosci. 2015;22(9):1505–1506.
   PubMed Web of Science ®Google Scholar
• Hessen E, Lossius MI, Gjerstad L. Improvement in verbal memory after withdrawal of carbamazepine and valproate in patients with well-controlled epilepsy: a randomized, double-blind study. Acta Neurol Scand. 2011;123(6):385–389.
   PubMed Web of Science ®Google Scholar
• Zou X, Hong Z, Chen J, et al. Is antiepileptic drug withdrawal status related to quality of life in seizure-free adult patients with epilepsy? Epilepsy Behav. 2014;31:129–135.
   PubMed Web of Science ®Google Scholar
• van Schooneveld MM, van EN, Boshuisen K, et al. Withdrawal of antiepileptic drugs improves psychomotor speed after childhood epilepsy surgery. Epilepsy Res. 2013;107(1–2):200–203.
   PubMed Web of Science ®Google Scholar
• Boshuisen K, van Schooneveld MM, Uiterwaal CS, et al. Intelligence quotient improves after antiepileptic drug withdrawal following pediatric epilepsy surgery. Ann Neurol. 2015;78(1):104–114.
   PubMed Web of Science ®Google Scholar
• Khan RB, Onar A. Seizure recurrence and risk factors after antiepilepsy drug withdrawal in children with brain tumors. Epilepsia. 2006;47(2):375–379.
   PubMed Web of Science ®Google Scholar
• Koekkoek JA, Kerkhof M, Dirven L, et al. Withdrawal of antiepileptic drugs in glioma patients after long-term seizure freedom: design of a prospective observational study. BMCNeurol. 2014;14:157.
   Google Scholar
• Kilinc S, Campbell C. The experience of discontinuing antiepileptic drug treatment: an exploratory investigation. Seizure. 2008;17(6):505–513.
   PubMed Web of Science ®Google Scholar
• Hixson JD. Stopping antiepileptic drugs: when and why? Curr Treat Options Neurol. 2010;12(5):434–442.
   PubMed Web of Science ®Google Scholar
• Tellez-Zenteno JF, Ronquillo LH, Jette N, et al. Discontinuation of antiepileptic drugs after successful epilepsy surgery. a Canadian survey. Epilepsy Res. 2012;102(1–2):23–33.
   PubMed Web of Science ®Google Scholar
• Berg AT, Langfitt JT, Spencer SS, et al. Stopping antiepileptic drugs after epilepsy surgery: a survey of U.S. epilepsy center neurologists. Epilepsy Behav. 2007;10(2):219–222.
   PubMed Web of Science ®Google Scholar
• Swisher CB, Sinha SR. Survey of current practices among US epileptologists of antiepileptic drug withdrawal after epilepsy surgery. Epilepsy Behav. 2013;26(2):203–206.
   PubMed Web of Science ®Google Scholar
• Hemb M, Velasco TR, Parnes MS, et al. Improved outcomes in pediatric epilepsy surgery: the UCLA experience, 1986-2008. Neurology. 2010;74(22):1768–1775.
   PubMed Web of Science ®Google Scholar
• Kerling F, Pauli E, Lorber B, et al. Drug withdrawal after successful epilepsy surgery: how safe is it? Epilepsy & Behav. 2009;15(4):476–480.
   PubMed Web of Science ®Google Scholar
• Ranganathan LN, Ramaratnam S. Rapid versus slow withdrawal of antiepileptic drugs. Cochrane Database Syst Rev. 2006;2:CD005003.
   Google Scholar
• Gasparini S, Ferlazzo E, Giussani G, et al. Rapid versus slow withdrawal of antiepileptic monotherapy in 2-year seizure-free adult patients with epilepsy (RASLOW) study: a pragmatic multicentre, prospective, randomized, controlled study. Neurol Sci. 2016;37(4):579–583.
   PubMed Web of Science ®Google Scholar